# Effects of Cardiopulmonary Bypass (CPB)-Leukocyte Filtration on Interleukins Serum Levels and Pulmonary Function

> **NCT01469676** · NA · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 22 (actual)

## Conditions studied

- Systemic Inflammatory Response Syndrome (SIRS)
- Leukocyte Disorders
- Complications Due to Coronary Artery Bypass Graft

## Interventions

- **DEVICE:** Filtering group LG-6, Pall Biomedical Products

## Key facts

- **NCT ID:** NCT01469676
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2010-02
- **Final completion:** 2010-10
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2011-11-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01469676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01469676, "Effects of Cardiopulmonary Bypass (CPB)-Leukocyte Filtration on Interleukins Serum Levels and Pulmonary Function". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01469676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*